Mutation screening in children with Congenital anomalies of the kidney and urinary tract (CAKUT) using Next generation sequencing (NGS) platform.
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2016 - 65535
Project Lead
Dr. Shubha AM
Authors
Dr. Shubha AM
Project Status
completed
Project Type
RGUHS